Avidity Biosciences, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2020-06-11

Reporting Person: ELI LILLY & Co (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series C Preferred Stock	$0		Common Stock (4576342)		Direct

Footnotes

F1: Shares of Series C Preferred Stock are convertible at any time, at the holder's election, at a ratio of one-for-2.1095 shares of the Issuer's Common Stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series C Preferred Stock will automatically convert at a ratio of one-for-2.1095 shares of the Issuer's Common Stock. The Series C Preferred Stock has no expiration date.